Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 28
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Protoplasma ; 228(4): 201-8, 2006 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16983487

RESUMO

Although calcium carbonate is known to be a common biomineral in plants, very little attention has been given to the biological control of calcium carbonate deposition. In mulberry leaves, a subcellular structure is involved in mineral deposition and is described here by a variety of cytological techniques. Calcium carbonate was deposited in large, rounded idioblast cells located in the upper epidermal layer of mulberry leaves. Next to the outmost region ("cap") of young idioblasts, we found that the inner cell wall layer expanded to form a peculiar outgrowth, named cell wall sac in this report. This sac grew and eventually occupied the entire apoplastic space of the idioblast. Inside the mature cell wall sac, various cellulosic membranes developed and became the major site of Ca carbonate deposition. Concentrated Ca2+ was pooled in the peripheral zone, where small Ca carbonate globules were present in large numbers. Large globules were tightly packed among multiple membranes in the central zone, especially in compartments formed by cellulosic membranes and in their neighboring membranes. The maximum Ca sink capacity of a single cell wall sac was quantified using enzymatically isolated idioblasts as approximately 48 ng. The newly formed outgrowth in idioblasts is not a pure calcareous body but a complex cell wall structure filled with substantial amounts of Ca carbonate crystals.


Assuntos
Carbonato de Cálcio/metabolismo , Parede Celular/metabolismo , Morus/metabolismo , Cálcio/metabolismo , Parede Celular/ultraestrutura , Microscopia Eletrônica/métodos , Modelos Biológicos , Morus/citologia , Morus/ultraestrutura , Estruturas Vegetais/citologia , Estruturas Vegetais/metabolismo , Estruturas Vegetais/ultraestrutura
2.
Appl Opt ; 39(36): 6799-805, 2000 Dec 20.
Artigo em Inglês | MEDLINE | ID: mdl-18354694

RESUMO

A multiwavelength laser source composed of a single semiconductor optical amplifier and a commercially available off-the-shelf wavelength-division multiplexed (WDM) filter is constructed and tested under actively mode-locking operation. Five independent mode-locked wavelength channels are generated simultaneously, with a wavelength spacing of 1.6 nm established by the WDM filter. In addition, to demonstrate the potential of this mixed time-frequency, or hybrid WDM-optical time-division multiplexed, signal, we demonstrate a simple parallel-to-serial wavelength conversion to increase the pulse repetition rate of the mode-locked laser by a number of output wavelengths for applications in high-performance optical sampling applications.

3.
RNA ; 5(5): 707, 1999 May.
Artigo em Inglês | MEDLINE | ID: mdl-10375260
4.
Science ; 283(5410): 2019-20, 1999 Mar 26.
Artigo em Inglês | MEDLINE | ID: mdl-10206907
5.
Opt Lett ; 24(4): 238-40, 1999 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-18071466

RESUMO

Wideband spectral phase correlation is demonstrated from a multiwavelength mode-locked semiconductor laser. By use of frequency-resolved optical gating techniques, significant phase correlation was observed between multiple intracavity oscillating wavelengths, with wavelength separations of ~1 nm . The resultant temporal characteristics show a substantial modulation owing to the spectral coupling induced by intracavity-generated four-wave mixing. This result may lead to novel methods for directly generating ultrafast subpicosecond optical pulse sequences with spectrally tailored amplitude and phase characteristics from actively mode-locked semiconductor lasers.

6.
Biol Chem ; 379(7): 819-29, 1998 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-9705145

RESUMO

Previously we demonstrated that ribosomes can synthesize polypeptides in the presence of high concentrations (40-60%) of pyridine without any protein factors. Here we analyze additional ribosomal parameters in 60% pyridine using Escherichia coli ribosomes. Ribosomal subunits once exposed to pyridine failed to re-associate to 70S ribosomes in aqueous buffer systems even in the presence of 20 mM Mg2+, whereas they formed 70S complexes in the presence of 60% pyridine. Two-dimensional gel electrophoresis of ribosomal proteins revealed that some proteins located at the protuberances of the large subunit, e. g. L7/L12 and L11 forming the elongation factor-binding domain, were released in the pyridine system. The aminoglycoside neomycin, a strong inhibitor of the ribosomal (factor-independent) translocation reaction, completely blocked poly(Phe) synthesis and translocation activities in the pyridine system, whereas these activities were not affected at all by gypsophilin, a ribotoxin that inhibits factor-dependent translocation. Another inhibitor of the ribosomal translocation, thiostrepton, had no effect concerning the two activities, which is consistent with the fact that this antibiotic requires L11 for its binding to the ribosome. These results suggest that the ribosomes can perform a translocation reaction in the pyridine system, but in a factor-independent (spontaneous) manner.


Assuntos
Biossíntese Peptídica , Piridinas/metabolismo , Sistema Livre de Células , Transferência de Energia , Peptídeos/metabolismo , Biossíntese de Proteínas , Proteínas Ribossômicas/metabolismo , Ribossomos
7.
Science ; 281(5377): 666-9, 1998 Jul 31.
Artigo em Inglês | MEDLINE | ID: mdl-9685252

RESUMO

It was recently demonstrated that peptide bond formation can occur using an Escherichia coli naked 23S ribosomal RNA without any of the ribosomal proteins. Here, the six domains of the 23S ribosomal RNA were individually synthesized and shown to be capable, when complexed together, of stimulating the reaction. Omission and addition experiments indicated that the activity could be reconstituted solely by domain V at a concentration 10 times higher than that of the intact 23S ribosomal RNA, whereas domain VI could enhance the activity in trans. These findings suggest that fragments of an RNA molecule have the ability to associate into a functional whole.


Assuntos
Escherichia coli/metabolismo , Biossíntese Peptídica , Peptidil Transferases/metabolismo , RNA Ribossômico 23S/metabolismo , Aminoacil-RNA de Transferência/metabolismo , Catálise , Neomicina/farmacologia , Conformação de Ácido Nucleico , Inibidores da Síntese de Proteínas/farmacologia , RNA Bacteriano/química , RNA Bacteriano/metabolismo , RNA Ribossômico 23S/química , Esparsomicina/farmacologia , Transcrição Gênica
8.
RNA ; 4(3): 257-67, 1998 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-9510328

RESUMO

Experimental results are presented suggesting that 23S rRNA is directly involved in the peptide bond formation usually performed on the ribosome. Although several reports have indicated that the eubacterial peptidyltransferase reaction does not necessarily require all the ribosomal proteins, the reconstitution of peptidyltransferase activity by a naked 23S rRNA without the help of any of the ribosomal proteins has not been reported previously. It is demonstrated that an E. coli 23S rRNA transcript synthesized by T7 RNA polymerase in vitro was able to promote peptide bond formation in the presence of 0.5% SDS. The reaction was inhibited by the peptidyltransferase-specific antibiotics chloramphenicol and carbomycin, and by digestion with RNases A and T1. Site-directed mutageneses at two highly conserved regions close to the peptidyltransferase center ring, G2252 to U2252 and C2507G2581 to U2507A2581, also suppressed peptide bond formation. These findings strongly suggest that 23S rRNA is the peptidyltransferase itself.


Assuntos
Escherichia coli/genética , Peptídeos/metabolismo , RNA Ribossômico 23S/genética , RNA Ribossômico 23S/metabolismo , Cloranfenicol/farmacologia , Dipeptídeos/química , Dipeptídeos/metabolismo , Cinética , Leucomicinas/farmacologia , Mutação , Peptídeos/química , Peptidil Transferases/metabolismo , RNA Ribossômico/metabolismo , RNA Ribossômico 23S/efeitos dos fármacos , Aminoacil-RNA de Transferência/metabolismo , RNA de Transferência de Fenilalanina/metabolismo , Ribonucleases/metabolismo , Dodecilsulfato de Sódio/química , Transcrição Gênica
9.
J Biochem ; 119(6): 1076-9, 1996 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-8827440

RESUMO

We demonstrate here that ribosomes from not only Escherichia coli and Thermus thermophilus [Nitta et al. (1994) J. Biochem. 115, 803-807; ibid., (1995) 118, 841-849] but also yeast and bovine mitochondria catalyze peptide synthesis promoted by a high concentration of pyridine in the absence of soluble protein factors and chemical energy sources, and compare some characteristic features of the reactions among these organisms. Sensitivities against antibiotics, chloramphenicol and cycloheximide, showed the same tendency to those in the in vitro aqueous translation systems of these organisms, suggesting that the basic mechanism for peptide synthesis is the same among these organisms. The optimal concentration of pyridine was centered at 50% for all systems, although the dependencies on the pyridine concentrations and the yields of the products were different from one another. All these systems required Mg2+, and only mitochondrial system showed the extra Mn(2+)-requirement, which enhanced the yield by several fold. The optimum reaction temperatures coincided closely with the growing temperatures of the organisms except for the mitochondrial system, which showed the highest activity above 80 degrees C. The rationale for these observations remains to be solved.


Assuntos
Biossíntese Peptídica , Peptídeos , Piridinas/farmacologia , Ribossomos/efeitos dos fármacos , Animais , Bovinos , Cloranfenicol/farmacologia , Cicloeximida/farmacologia , Escherichia coli/efeitos dos fármacos , Escherichia coli/metabolismo , Magnésio/farmacologia , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/metabolismo , Biossíntese de Proteínas , Inibidores da Síntese de Proteínas/farmacologia , Aminoacil-RNA de Transferência/metabolismo , Saccharomyces cerevisiae/efeitos dos fármacos , Saccharomyces cerevisiae/metabolismo , Temperatura , Thermus thermophilus/efeitos dos fármacos , Thermus thermophilus/metabolismo
10.
J Biochem ; 118(4): 841-9, 1995 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-8576102

RESUMO

We demonstrate here that a high concentration (40-70%) of pyridine, an aromatic tertiary amine catalyst, is able to promote translation on ribosomes without the presence of soluble protein factors or chemical energy sources. Compared with Monro's fragment reaction [Methods Enzymol. 20, 472-481 (1971)] which reflects only the peptidyltransferase step, this novel translation system can produce polypeptides with chain lengths of at least several tens of residues depending on the template RNA. In the presence of 60% pyridine, poly(U) and poly(UC) promoted incorporation of the respective amino acids, phenylalanine and serine-leucine, twofold, whereas poly(A) promoted the incorporation of lysine by only 25%. The degrees of polymerization of phenylalanine and lysine were up to the decamer and around 40mer, respectively. In poly(UC)-dependent oligo(serine-leucine) synthesis, oligopeptides with a serine and leucine alternate sequence were the main products. This novel pyridine system evidently differs from the non-enzymatic translation system reported by Gavrilova and Spirin [FEBS Lett. 17, 324-326 (1971)]; the former system displays partial resistance toward deproteinization reagents such as SDS and proteinase K, whereas the latter system is completely sensitive.


Assuntos
Escherichia coli/genética , Biossíntese de Proteínas , Piridinas/metabolismo , Ribossomos/genética , Escherichia coli/metabolismo , Ribossomos/metabolismo , Moldes Genéticos
11.
J Biochem ; 118(4): 850-4, 1995 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-8576103

RESUMO

We have already reported a novel, in vitro translation system, promoted by pyridine instead of the usual protein factors and energy sources, which consists of only salt-washed ribosomes from Escherichia coli, aminoacyl-tRNA, a template RNA, Na+ and Mg2+ cations, and 40-60% pyridine [Nitta et al. (1994) J. Biochem. 115, 803-807 and the accompanying paper]. Here we show that in this system, pyridine can be replaced not only by pyridine derivatives but also by nucleobases or nucleosides, demonstrating that any compound harboring an aromatic tertiary amine within the molecule possesses such promoting activity. These compounds may serve to assist the peptide bond formation catalyzed by peptidyltransferase within ribosomes. The finding that nucleobases and nucleosides can play such a role in this reaction implies the possibility that these compounds were directly involved in the premordial translation system.


Assuntos
Aminas/metabolismo , Escherichia coli/metabolismo , Biossíntese de Proteínas , Ribossomos/metabolismo , Escherichia coli/genética , Ácidos Nucleicos/metabolismo
12.
J Biochem ; 115(4): 803-7, 1994 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-8089098

RESUMO

We found that poly(U)-dependent polyphenylalanine synthesis on Escherichia coli ribosomes was extremely accelerated in the presence of a high concentration of pyridine. In this reaction, chemical energy sources, such as ATP and GTP, and soluble protein factors are not required, but the template and ribosomes are essential for the progress of the reaction. The reaction was inhibited by the antibiotics which inhibit the usual bacterial translation process on the ribosomes. These observations clearly demonstrate that the pyridine-catalyzed amino acid condensation reaction proceeds on the ribosome.


Assuntos
Biossíntese Peptídica , Peptídeos/efeitos dos fármacos , Biossíntese de Proteínas/efeitos dos fármacos , Piridinas/farmacologia , Ribossomos/efeitos dos fármacos , Moldes Genéticos , Proteínas de Bactérias/metabolismo , Catálise , Escherichia coli/efeitos dos fármacos , Escherichia coli/metabolismo , Aminoacil-RNA de Transferência , Solubilidade
13.
Jpn J Antibiot ; 46(12): 1063-74, 1993 Dec.
Artigo em Japonês | MEDLINE | ID: mdl-8107269

RESUMO

We studied the pharmacokinetics of a new cephem antibiotic, S-1108, in patients with impaired kidney functions. Serum and urinary levels of S-1006 were determined after oral administration of S-1108 at 150 mg to 9 patients with renal dysfunction. In patients with severe renal impairment, high serum levels were maintained over long periods of time. Urinary excretion rates of S-1006 were lower as degrees of kidney failure were severer. S-1108 was administered to treat 27 patients with respiratory tract infections, and its clinical efficacy and safety were evaluated. The clinical efficacies were good in 26 patients, but poor in 1, yielding an efficacy rate of 96.3%. As to adverse reactions; diarrhea was observed in one case. Laboratory tests revealed elevated GOT and GPT in 1, and elevated gamma-GTP in another. These abnormalities, however, were slight and no severe side effects were caused by the drug.


Assuntos
Cefalosporinas/farmacocinética , Nefropatias/metabolismo , Pró-Fármacos/farmacocinética , Infecções Respiratórias/tratamento farmacológico , Administração Oral , Adulto , Idoso , Idoso de 80 Anos ou mais , Cefalosporinas/administração & dosagem , Feminino , Meia-Vida , Humanos , Masculino , Pessoa de Meia-Idade , Pró-Fármacos/administração & dosagem
14.
Jpn J Antibiot ; 46(8): 637-46, 1993 Aug.
Artigo em Japonês | MEDLINE | ID: mdl-8230733

RESUMO

We studied the pharmacokinetics of a new cephem antibiotic, DQ-2556, in patients with impaired kidney function. The peak concentrations of the compound in the serum were observed irrespective of the degree of kidney failure 5 minutes after its bolus administration of 1.0 g intravenously, and no significant difference was observed in the concentrations among the patients. On the other hand, the decrease in its concentrations in the serum was impeded in proportion to degrees of kidney failure and, in particular, hemodialysis patients showed markedly delayed clearance of the drug from the serum; the half-lives in the serum (beta phase) were prolonged to ca. 6 hours in patients with severe kidney failure (Ccr ca. 20 ml/min) and did so markedly to ca. 17 to 21 hours in patients with hemodialysis as compared with ca. 2.5 hours in patients with slight kidney failure (Ccr ca. 50 ml/min). Urinary excretion rates (0-to-24 hours values) were ca. 70% in patients with slight kidney failure, ca. 60% in patients with moderate kidney failure and ca. 40% in patients with severe kidney failure, showing a tendency toward a decline in relation to increasing degrees of kidney failure. The compound showed a satisfactory dialytic property. The clinical efficacy and safety of DQ-2556 were evaluated upon administering if at daily doses of 0.5 g b.i.d. and 1.0 g b.i.d. for 7 and 14 consecutive days respectively, in patients with lower respiratory tract infections. The clinical efficacies were excellent in 2 patients, good in 11 and poor in 2, yielding a efficacy rate of 86.7%. No side effects were observed, though, a neutrophil sedimentation ratio decreased in a patient, and a down-shift of prothrombin activities was observed in another. These results suggest that DQ-2556 is useful for lower respiratory tract infections, but in patients with kidney failures it is required to seek the most suitable regimen since the excretion rates of the compound decrease as degrees of kidney failure become severer.


Assuntos
Cefalosporinas/farmacocinética , Rim/metabolismo , Infecções Respiratórias/tratamento farmacológico , Adulto , Idoso , Idoso de 80 Anos ou mais , Cefalosporinas/administração & dosagem , Cefalosporinas/farmacologia , Avaliação de Medicamentos , Feminino , Meia-Vida , Humanos , Injeções Intravenosas , Masculino , Pessoa de Meia-Idade , Insuficiência Renal/metabolismo
15.
J Med Chem ; 35(25): 4713-9, 1992 Dec 11.
Artigo em Inglês | MEDLINE | ID: mdl-1469700

RESUMO

The effect of substitution in the acyclic structure of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)-thymine (HEPT) on anti-HIV-1 activity was investigated by synthesizing a series of deoxy analogs and related compounds. Preparation of 1-[(2-alkyloxyethoxy)methyl]-6- (phenylthio)thymine (2-4) derivatives was carried out based on alkylation of HEPT with primary alkyl halides. Preparation of the 1-[(alkyloxy)methyl]-6-(phenylthio)thymine (26-31) and 1-[(alkyloxy)methyl]-6-(arylthio)-2-thiouracil (32-45) derivatives was carried out on the basis of LDA lithiation of 1-[(alkyloxy)-methyl]thymine (9-14) and 1-[(alkyloxy)methyl]-2-thiouracil (15-25) followed by reaction with diaryl disulfides. The oxidative hydrolysis of the 2-thiouracil derivatives gave 1-[(alkyloxy)methyl]-6-(arylthio)uracil derivatives (46-57). 1-Alkyl-6-(phenylthio)thymine (59-61) derivatives were prepared on the basis of alkylation of 6-(phenylthio)thymine (58). Methylation of the hydroxyl group of HEPT did not affect the anti-HIV-1 activity of HEPT. Substitution of the 1-(2-hydroxyethoxy)methyl group by ethyl, butyl, methoxymethyl, (propyloxy)methyl, and (butyloxy)-methyl groups somewhat improved the original anti-HIV-1 activity of HEPT. Substitution with ethoxymethyl and (benzyloxy)methyl groups further potentiated the activity [EC50: 1-(ethoxy-methyl)-6-(phenylthio)thymine (27), 0.33 microM; 1-[(benzyloxy)methyl]-6-(phenylthio)thymine (31), 0.088 microM]. When the 5-methyl group of 27 and 31 was replaced by an ethyl or an isopropyl group, the anti-HIV-1 activity was improved remarkably [EC50: 5-ethyl-1-(ethoxymethyl)-6-(phenylthio)-uracil (46), 0.019 microM; 5-ethyl-1-[(benzyloxy)methyl]-6-(phenylthio)uracil (52), 0.0059 microM; 5-isopropyl-1-(ethoxymethyl)-6-(phenylthio)uracil (55), 0.012 microM; 5-isopropyl-1-[(benzyloxy)methyl]-6-(phenylthio)uracil (56), 0.0027 microM]. Introduction of two m-methyl groups into the phenylthio ring also potentiated the activity.


Assuntos
Antivirais/síntese química , HIV-1/efeitos dos fármacos , Timina/análogos & derivados , Antivirais/química , Antivirais/farmacologia , Células Cultivadas , Relação Estrutura-Atividade , Timina/síntese química , Timina/farmacologia , Replicação Viral/efeitos dos fármacos
16.
Jpn J Antibiot ; 45(5): 530-8, 1992 May.
Artigo em Japonês | MEDLINE | ID: mdl-1512939

RESUMO

We studied a newly developed oral quinolone antimicrobial agent, levofloxacin (LVFX, DR-3355), and obtained the following results. 1. Serum and urine levels of LVFX were determined after oral administration of LVFX 100 mg to 11 elderly patients with various degrees of renal function insufficiencies. The patients were classified according to creatinine clearance (Ccr) values into Group I (n = 1, Ccr greater than or equal to 70 ml/min), Group II (n = 4, 40 less than or equal to Ccr less than 70 ml/min), and Group III (n = 6, Ccr less than 40 ml/min). The peak levels of LVFX did not differ greatly among the 3 groups, but in patients with severely impaired renal functions, serum concentrations decreased more slowly than in those with slightly and moderately impaired renal functions, and high serum levels were maintained over a long period. Urinary excretion of LVFX diminished in relation to degrees of renal failure. 2. LVFX was administered to treat 13 elderly patients with respiratory tract infections. Clinical responses were good in all patients with a high efficacy rate of 100%. Laboratory tests revealed eosinophilia in 1 case. The symptom was mild, however, and no severe side effects due to the drug were observed.


Assuntos
Idoso , Levofloxacino , Ofloxacino/uso terapêutico , Infecções Respiratórias/tratamento farmacológico , Idoso de 80 Anos ou mais , Avaliação de Medicamentos , Feminino , Humanos , Nefropatias/metabolismo , Masculino , Ofloxacino/efeitos adversos , Ofloxacino/farmacocinética
17.
J Med Chem ; 35(2): 337-45, 1992 Jan 24.
Artigo em Inglês | MEDLINE | ID: mdl-1732552

RESUMO

The effect of substitution on the pyrimidine moiety of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) and 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)-2-thiothymine (HEPT-S) on anti-HIV-1 activity was investigated by synthesizing a series of 5-methyl-6-(arylthio) and 5-substituted-6-(phenylthio) derivatives. Preparation of the 5-methyl-6-(arylthio) derivatives was carried out based on either LDA lithiation of 1-[[2-(tert-butyldimethylsiloxy)ethoxy]methyl]thymine (3) and 1-[[2-(tert-butyldimethylsiloxy)ethoxy]methyl]-2-thiothymine (4) followed by reaction with diaryl disulfides or an addition-elimination reaction of 1-[[2-(tert-butyldimethylsiloxy)ethoxy]-methyl]-6- (phenylsulfinyl)thymine (31) with aromatic thiols. Preparation of the 5-substituted-6-(phenylthio) derivatives was carried out based on either C-5 lithiation of the 1-[[2-(tert-butyldimethylsiloxy)ethoxy]methyl]-6-(phenylthio)uraci l (41) with LTMP or the LDA lithiation of 5-alkyl-1-[[2-(tert-butyldimethylsiloxy)ethoxy]methyl]-2-thiouraci l derivatives 45-47. Substitution at the meta position of the C-6-(phenylthio) ring by the methyl group improved the original anti-HIV-1 activity of HEPT, and introduction of two m-methyl groups to the phenylthio ring further potentiated the activity [EC50: 6-[(3,5-dimethylphenyl)thio]-1-[(2-hydroxyethoxy)methyl]thymine (28), 0.26 microM; 6-[(3,5-dimethylphenyl)thio]-1-[(2-hydroxyethoxy)methyl]-2-thiothymin e (30), 0.22 microM]. When the 5-methyl group was replaced by an ethyl or an isopropyl group, the anti-HIV-1 activity of HEPT was also improved remarkably [EC50: 5-ethyl-1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)-2-thiouracil (48), 0.11 microM; 5-isopropyl-1-[(2-hydroxyethoxy)-methyl]-6-(phenylthio)-2-thiouracil (50), 0.059 microM; 5-ethyl-1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)-2-thiouracil (54), 0.12 microM; 5-isopropyl-1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)-2-thiouracil (56), 0.063 microM]. 6-[(3,5-Dimethylphenyl)thio]-5-ethyl-1-[(2-hydroxyethoxy)methyl]thymine derivatives 51 and 57 and 6-[(3,5-dimethylphenyl)thio]-5-isopropyl-1-[(2- hydroxyethoxy)methyl]thymine derivatives 52 and 58 inhibited the replication of HIV-1 in the nanomolar concentration range.


Assuntos
Antivirais/química , HIV-1/efeitos dos fármacos , Timina/análogos & derivados , Antivirais/síntese química , Antivirais/farmacologia , Linhagem Celular , Sobrevivência Celular/efeitos dos fármacos , Efeito Citopatogênico Viral/efeitos dos fármacos , HIV-2/efeitos dos fármacos , Relação Estrutura-Atividade , Timina/síntese química , Timina/química , Timina/farmacologia , Replicação Viral/efeitos dos fármacos
18.
J Med Chem ; 34(8): 2468-73, 1991 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-1875343

RESUMO

A series of 21-desoxy-21-chlorocorticosteroids that contain a functionalized ester group at 17 alpha has been prepared and examined to separate their systemic activity from topical antiinflammatory activity. Introduction of the functionalized ester group at 17 alpha was carried out by an acid-catalyzed formation of cyclic ortho esters with 17 alpha,21-hydroxyl groups of corticosteroids and subsequent acid-catalyzed hydrolysis. As for the functional group, chloro, methoxy, acetoxy, cyano, cyclopropyl, or alkoxycarbonyl group was introduced at the terminal carbon atom of the 17 alpha-alkanoate group. The topical antiinflammatory activity and systemic activity of these compounds were examined and found to be significantly dependent on the functionalities in the 17 alpha-esters. Among these derivatives, a series of 17 alpha-(alkoxycarbonyl)alkanoates (17 alpha-OCO(CH2)nCOOR) showed an excellent separation of the systemic activity from topical activity. The effects of the number of methylene groups (n) and of the alkyl groups of the ester (R) on either topical or systemic activity of the corticosteroid derivatives were also investigated.


Assuntos
Corticosteroides/síntese química , Anti-Inflamatórios/síntese química , Administração Tópica , Corticosteroides/metabolismo , Corticosteroides/uso terapêutico , Animais , Anti-Inflamatórios/metabolismo , Anti-Inflamatórios/uso terapêutico , Fenômenos Químicos , Química , Óleo de Cróton , Edema/tratamento farmacológico , Esterificação , Granuloma/induzido quimicamente , Granuloma/tratamento farmacológico , Fígado/metabolismo , Masculino , Camundongos , Estrutura Molecular , Otite/induzido quimicamente , Otite/tratamento farmacológico , Ratos , Ratos Endogâmicos , Receptores de Glucocorticoides/metabolismo , Esteroides , Relação Estrutura-Atividade
19.
Mol Pharmacol ; 39(6): 805-10, 1991 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-1711148

RESUMO

In the search for novel derivatives of 1-[2-(hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT), we have found that several 5-ethyl-6-(3,5-dimethylphenylthio)uracil and 5-ethyl-6-(3,5-dimethylbenzyl)uracil analogues are exquisitely potent and selective inhibitors of human immunodeficiency virus type 1 (HIV-1) replication in a variety of cell culture systems. Of this series, 5-ethyl-1-ethoxymethyl-6-(3,5-dimethylbenzyl)uracil (E-EBU-dM) emerged as the most active congener. Its 50% inhibitory concentration for HIV-1 (HTLV-IIIB) in MT-4 cells and peripheral blood lymphocytes is 2.2 and 0.45 nM, respectively. These concentrations are more than 10(5)-fold lower than the 50% cytotoxic concentrations of E-EBU-dM for the host cells. All compounds proved equally inhibitory to a number of clinical HIV-1 isolates, including a 3'-azido-2',3'-dideoxythymidine-resistant variant. However, as previously noted for HEPT, they do not inhibit human immunodeficiency virus type 2 replication. Reverse transcriptase assays have revealed that these HEPT derivatives act specifically on HIV-1 reverse transcriptase, according to a mechanism that is different from that of the dideoxynucleosides.


Assuntos
Antivirais/farmacologia , HIV-1/efeitos dos fármacos , Timina/análogos & derivados , Humanos , Inibidores da Transcriptase Reversa , Relação Estrutura-Atividade , Timina/farmacologia , Zidovudina/farmacologia
20.
J Med Chem ; 34(4): 1394-9, 1991 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-2016715

RESUMO

Several analogues of a new lead for anti-HIV-1 agents, 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT), in which the C-2, N-3, or C-4 position was modified were synthesized. These involve 2-thiothymine (11), 2-thiouracil (12), 4-thiothymine (17), 4-thiouracil (18), 5-methylcytosine (27), and cytosine (28) derivatives. Preparation of N-3-substituted derivatives (29 and 30) of HEPT was also carried out. Among these analogues, compound 11 exhibited excellent activity against HIV-1 HTLV-IIIB strain with an EC50 value of 0.98 microM, which is 7-fold more potent than that of HEPT. Removal of the 5-methyl group in compound 11 results in total loss of activity. Other compounds did not show any anti-HIV-1 activity. The 4-thio derivatives 17 and 18 were found to be rather cytotoxic. When compound 11 was evaluated for its inhibitory effects on another HIV-1 strain, HTLV-IIIRE, and two HIV-2 strains, LAV-2ROD and LAV-2EHO, it proved equally inhibitory to HTLV-IIIRF, whereas both HIV-2 strains were insensitive to the compound.


Assuntos
Antivirais/síntese química , HIV-1/efeitos dos fármacos , HIV-2/efeitos dos fármacos , Timina/análogos & derivados , Timina/síntese química , Linhagem Celular , Células Cultivadas , HIV-1/fisiologia , HIV-2/fisiologia , Humanos , Indicadores e Reagentes , Ativação Linfocitária , Linfócitos/citologia , Linfócitos/imunologia , Linfócitos/microbiologia , Espectroscopia de Ressonância Magnética , Estrutura Molecular , Relação Estrutura-Atividade , Timina/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA